SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
National Cancer Institute at SNO 2026
Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website
National Cancer Institute brings 12 presentations to SNO 2026 in Philadelphia. Its program covers early trials for recurrent gliomas, including IDH-mutant tumors, and metabolic vulnerabilities found in the lab. The institute also presents its funding for early-stage neuro-oncology startups.
| Organization | SNO 2026 Attendance |
|---|---|
National Cancer Institute Bethesda, MD | |
A U.S. federal institute that supports cancer research and provides information on cancer prevention, diagnosis, and treatment. | Plenary Fri Nov 13 9:50–10am Talk Fri Nov 13 12:15–12:18pm Talk Fri Nov 13 12:27–12:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Talk Sat Nov 14 11:39–11:42am Talk Sat Nov 14 12:15–12:18pm |
Find decision makers at National Cancer Institute
Tell us what you sell and we’ll find the people at National Cancer Institute most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction